Skip to content
10-Q

Quarterly Report

NORTHSTAR HEALTHCARE INCOME, INC.

0001503707-24-000032

← back to feed
Filed
Aug 12, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 12, 2024 185.71M sh
Shares Diluted Q2 2024 · Jun 30, 2024 185.71M sh
Shares Diluted Q2 2024 · Jun 30, 2024 185.71M sh
Shares Diluted Q2 2024 · Jun 30, 2023 193.16M sh
Shares Diluted Q2 2024 · Jun 30, 2023 194.28M sh
Stock Repurchased Q2 2024 · Jun 30, 2024 $0
Stock Repurchased Q2 2024 · Jun 30, 2023 $1.28M
Operating Cash Flow Q2 2024 · Jun 30, 2024 $8.73M
Operating Cash Flow Q2 2024 · Jun 30, 2023 $11.26M
Long Term Debt Q2 2024 · Jun 30, 2024 $884.18M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $82.21M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $85.04M
Stockholders Equity Q2 2024 · Jun 30, 2024 $114.92M
Stockholders Equity Q2 2024 · Dec 31, 2023 $132.89M
Total Liabilities Q2 2024 · Jun 30, 2024 $914.33M
Total Liabilities Q2 2024 · Dec 31, 2023 $927.74M
Total Assets Q2 2024 · Jun 30, 2024 $1.03B
Total Assets Q2 2024 · Dec 31, 2023 $1.06B
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.05
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.10
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.30
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.37
Eps Basic Q2 2024 · Jun 30, 2024 −$0.05
Eps Basic Q2 2024 · Jun 30, 2024 −$0.10
Eps Basic Q2 2024 · Jun 30, 2023 −$0.30
Eps Basic Q2 2024 · Jun 30, 2023 −$0.37
Sga Expense Q2 2024 · Jun 30, 2024 $3.15M
Sga Expense Q2 2024 · Jun 30, 2024 $6.48M
Sga Expense Q2 2024 · Jun 30, 2023 $3.59M
Sga Expense Q2 2024 · Jun 30, 2023 $7.5M
Gross Profit Q2 2024 · Jun 30, 2024 $17.85M
Gross Profit Q2 2024 · Jun 30, 2024 $33.22M
Gross Profit Q2 2024 · Jun 30, 2023 $16.48M
Gross Profit Q2 2024 · Jun 30, 2023 $30.97M
Cost Of Revenue Q2 2024 · Jun 30, 2024 $32.41M
Cost Of Revenue Q2 2024 · Jun 30, 2024 $65.79M
Cost Of Revenue Q2 2024 · Jun 30, 2023 $35.03M
Cost Of Revenue Q2 2024 · Jun 30, 2023 $70.1M
Revenue Q2 2024 · Jun 30, 2024 $50.26M
Revenue Q2 2024 · Jun 30, 2024 $99.01M
Revenue Q2 2024 · Jun 30, 2023 $51.5M
Revenue Q2 2024 · Jun 30, 2023 $101.07M